List of Tables
Table 1. Global Cognition-Enhancing Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Cognition-Enhancing Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Cognition-Enhancing Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Cognition-Enhancing Drugs Sales (K MT) of Key Manufacturers (2018-2023)
Table 5. Global Cognition-Enhancing Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Cognition-Enhancing Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Cognition-Enhancing Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Cognition-Enhancing Drugs Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Cognition-Enhancing Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Cognition-Enhancing Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cognition-Enhancing Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Cognition-Enhancing Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cognition-Enhancing Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cognition-Enhancing Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cognition-Enhancing Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Cognition-Enhancing Drugs Sales by Region (2018-2023) & (K MT)
Table 18. Global Cognition-Enhancing Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Cognition-Enhancing Drugs Sales by Region (2024-2029) & (K MT)
Table 20. Global Cognition-Enhancing Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Cognition-Enhancing Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Cognition-Enhancing Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Cognition-Enhancing Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Cognition-Enhancing Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Cognition-Enhancing Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Cognition-Enhancing Drugs Sales by Country (2018-2023) & (K MT)
Table 27. North America Cognition-Enhancing Drugs Sales by Country (2024-2029) & (K MT)
Table 28. North America Cognition-Enhancing Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Cognition-Enhancing Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Cognition-Enhancing Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Cognition-Enhancing Drugs Sales by Country (2018-2023) & (K MT)
Table 32. Europe Cognition-Enhancing Drugs Sales by Country (2024-2029) & (K MT)
Table 33. Europe Cognition-Enhancing Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Cognition-Enhancing Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Cognition-Enhancing Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Cognition-Enhancing Drugs Sales by Region (2018-2023) & (K MT)
Table 37. Asia Pacific Cognition-Enhancing Drugs Sales by Region (2024-2029) & (K MT)
Table 38. Asia Pacific Cognition-Enhancing Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Cognition-Enhancing Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Cognition-Enhancing Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Cognition-Enhancing Drugs Sales by Country (2018-2023) & (K MT)
Table 42. Latin America Cognition-Enhancing Drugs Sales by Country (2024-2029) & (K MT)
Table 43. Latin America Cognition-Enhancing Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cognition-Enhancing Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Cognition-Enhancing Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Cognition-Enhancing Drugs Sales by Country (2018-2023) & (K MT)
Table 47. Middle East & Africa Cognition-Enhancing Drugs Sales by Country (2024-2029) & (K MT)
Table 48. Middle East & Africa Cognition-Enhancing Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Cognition-Enhancing Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Cognition-Enhancing Drugs Sales (K MT) by Type (2018-2023)
Table 51. Global Cognition-Enhancing Drugs Sales (K MT) by Type (2024-2029)
Table 52. Global Cognition-Enhancing Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Cognition-Enhancing Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Cognition-Enhancing Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Cognition-Enhancing Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Cognition-Enhancing Drugs Price (USD/MT) by Type (2018-2023)
Table 59. Global Cognition-Enhancing Drugs Price (USD/MT) by Type (2024-2029)
Table 60. Global Cognition-Enhancing Drugs Sales (K MT) by Application (2018-2023)
Table 61. Global Cognition-Enhancing Drugs Sales (K MT) by Application (2024-2029)
Table 62. Global Cognition-Enhancing Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Cognition-Enhancing Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Cognition-Enhancing Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Cognition-Enhancing Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Cognition-Enhancing Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Cognition-Enhancing Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Cognition-Enhancing Drugs Price (USD/MT) by Application (2018-2023)
Table 69. Global Cognition-Enhancing Drugs Price (USD/MT) by Application (2024-2029)
Table 70. Accelerated Intelligence Corporation Information
Table 71. Accelerated Intelligence Description and Business Overview
Table 72. Accelerated Intelligence Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 73. Accelerated Intelligence Cognition-Enhancing Drugs Product
Table 74. Accelerated Intelligence Recent Developments/Updates
Table 75. Cognition Therapeutics Corporation Information
Table 76. Cognition Therapeutics Description and Business Overview
Table 77. Cognition Therapeutics Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 78. Cognition Therapeutics Cognition-Enhancing Drugs Product
Table 79. Cognition Therapeutics Recent Developments/Updates
Table 80. Cogstate Corporation Information
Table 81. Cogstate Description and Business Overview
Table 82. Cogstate Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 83. Cogstate Cognition-Enhancing Drugs Product
Table 84. Cogstate Recent Developments/Updates
Table 85. HVMN Corporation Information
Table 86. HVMN Description and Business Overview
Table 87. HVMN Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 88. HVMN Cognition-Enhancing Drugs Product
Table 89. HVMN Recent Developments/Updates
Table 90. Biogen Idec Corporation Information
Table 91. Biogen Idec Description and Business Overview
Table 92. Biogen Idec Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 93. Biogen Idec Cognition-Enhancing Drugs Product
Table 94. Biogen Idec Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Cognition-Enhancing Drugs Distributors List
Table 98. Cognition-Enhancing Drugs Customers List
Table 99. Cognition-Enhancing Drugs Market Trends
Table 100. Cognition-Enhancing Drugs Market Drivers
Table 101. Cognition-Enhancing Drugs Market Challenges
Table 102. Cognition-Enhancing Drugs Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cognition-Enhancing Drugs
Figure 2. Global Cognition-Enhancing Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Cognition-Enhancing Drugs Market Share by Type in 2022 & 2029
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Cognition-Enhancing Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Cognition-Enhancing Drugs Market Share by Application in 2022 & 2029
Figure 8. Hospital Pharmacies
Figure 9. Drug Stores
Figure 10. Retail Pharmacies
Figure 11. Global Cognition-Enhancing Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Cognition-Enhancing Drugs Market Size (2018-2029) & (US$ Million)
Figure 13. Global Cognition-Enhancing Drugs Sales (2018-2029) & (K MT)
Figure 14. Global Cognition-Enhancing Drugs Average Price (USD/MT) & (2018-2029)
Figure 15. Cognition-Enhancing Drugs Report Years Considered
Figure 16. Cognition-Enhancing Drugs Sales Share by Manufacturers in 2022
Figure 17. Global Cognition-Enhancing Drugs Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Cognition-Enhancing Drugs Players: Market Share by Revenue in 2022
Figure 19. Cognition-Enhancing Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Cognition-Enhancing Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Cognition-Enhancing Drugs Sales Market Share by Country (2018-2029)
Figure 22. North America Cognition-Enhancing Drugs Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Cognition-Enhancing Drugs Sales Market Share by Country (2018-2029)
Figure 26. Europe Cognition-Enhancing Drugs Revenue Market Share by Country (2018-2029)
Figure 27. Germany Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Cognition-Enhancing Drugs Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Cognition-Enhancing Drugs Revenue Market Share by Region (2018-2029)
Figure 34. China Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Cognition-Enhancing Drugs Sales Market Share by Country (2018-2029)
Figure 45. Latin America Cognition-Enhancing Drugs Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Cognition-Enhancing Drugs Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Cognition-Enhancing Drugs Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. U.A.E Cognition-Enhancing Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Cognition-Enhancing Drugs by Type (2018-2029)
Figure 55. Global Revenue Market Share of Cognition-Enhancing Drugs by Type (2018-2029)
Figure 56. Global Cognition-Enhancing Drugs Price (USD/MT) by Type (2018-2029)
Figure 57. Global Sales Market Share of Cognition-Enhancing Drugs by Application (2018-2029)
Figure 58. Global Revenue Market Share of Cognition-Enhancing Drugs by Application (2018-2029)
Figure 59. Global Cognition-Enhancing Drugs Price (USD/MT) by Application (2018-2029)
Figure 60. Cognition-Enhancing Drugs Value Chain
Figure 61. Cognition-Enhancing Drugs Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed